Accès gratuit
Numéro
Med Sci (Paris)
Volume 25, Numéro 8-9, Août-Septembre 2009
Page(s) 699 - 704
Section M/S revues
DOI https://doi.org/10.1051/medsci/2009258-9699
Publié en ligne 15 août 2009
  1. Witko-Sarsat V, Rieu P, Descamps-Latscha B, et al. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000; 80 : 617–53. [Google Scholar]
  2. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005; 23 : 197–223. [Google Scholar]
  3. Gougerot-Pocidalo MA, El Benna J, My-Chan Dang P, et al. Quand les polynucléaires neutrophiles attrapent les agents pathogènes dans leurs filets. Med Sci (Paris) 2007;23 : 464–5. [Google Scholar]
  4. Chakravarti A, Allaeys I, Poubelle PE. Neutrophile et immunité : est-ce inné ou acquis ? Med Sci (Paris) 2007; 23 : 862–7. [Google Scholar]
  5. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995; 16 : 21–6. [Google Scholar]
  6. Cassatella MA. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999; 73 : 369–509. [Google Scholar]
  7. Dinarello CA. Proinflammatory cytokines. Chest 2000; 118 : 503–8. [Google Scholar]
  8. O’Dell JR. Anticytokine therapy: a new era in the treatment of rheumatoid arthritis ? N Engl J Med 1999; 340 : 310–2. [Google Scholar]
  9. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol 1994; 55 : 97–179. [Google Scholar]
  10. St-Onge M, Flamand N, Biarc J, et al. Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophils. Biochim Biophys Acta 2007;1771 : 1235–45. [Google Scholar]
  11. Hicks A, Monkarsh SP, Hoffman AF, et al. Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments. Expert Opin Investig Drugs 2007; 16 : 1909–20. [Google Scholar]
  12. Ham EA, Soderman DD, Zanetti ME, et al. Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci USA 1983; 80 : 4349–53. [Google Scholar]
  13. Oh-ishi S, Utsunomiya I, Yamamoto T, et al. Effects of prostaglandins and cyclic AMP on cytokine production in rat leukocytes. Eur J Pharmacol 1996; 300 : 255–9. [Google Scholar]
  14. Lawrence T, Gilroy DW. Chronic inflammation: a failure of resolution ? Int J Exp Pathol 2007; 88 : 85–94. [Google Scholar]
  15. Hurst SM, McLoughlin RM, Monslow J, et al. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells.J Immunol 2002; 169 : 5244–51. [Google Scholar]
  16. Hurst SM, Wilkinson TS, McLoughlin RM, et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14 : 705–14. [Google Scholar]
  17. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002;109 : 41–50. [Google Scholar]
  18. Bours MJ, Swennen EL, Di Virgilio F, et al. Adenosine 5’-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006;112 : 358–404. [Google Scholar]
  19. Hasko G, Linden J, Cronstein B, et al. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008; 7 : 759–70. [Google Scholar]
  20. Fortin A, Harbour D, Fernandes M, et al. Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide.J Leukoc Biol 2006; 79 : 574–85. [Google Scholar]
  21. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001; 414 : 916–20. [Google Scholar]
  22. Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993; 92 : 2675–82. [Google Scholar]
  23. Cronstein BN, Rosenstein ED, Kramer SB, et al. Adenosine: a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol 1985; 135 : 1366–71. [Google Scholar]
  24. Flamand N, Boudreault S, Picard S, et al. Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils. Am J Respir Crit Care Med 2000; 161 : S88–94. [Google Scholar]
  25. Cadieux JS, Leclerc P, St-Onge M, et al. Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal. J Cell Sci 2005; 118 : 1437–47. [Google Scholar]
  26. Pouliot M, Fiset ME, Masse M, et al. Adenosine up-regulates cyclooxygenase-2 in human granulocytes: impact on the balance of eicosanoid generation. J Immunol 2002; 169 : 5279–86. [Google Scholar]
  27. Surette ME, Krump E, Picard S, et al. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4). Mol Pharmacol 1999; 56 : 1055–62. [Google Scholar]
  28. McColl SR, St-Onge M, Dussault AA, et al. Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. Faseb J 2006; 20 : 187–9. [Google Scholar]
  29. Ernens I, Rouy D, Velot E, et al. Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2a receptor and cAMP/PKA/Ca2+ pathway. Circ Res 2006; 99 : 590–7. [Google Scholar]
  30. Wahl AF, Wallace PM. Oncostatin M in the anti-inflammatory response. Ann Rheum Dis 2001; 60 (suppl 3) : 75–80. [Google Scholar]
  31. Revan S, Montesinos MC, Naime D, et al. Adenosine A2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J Biol Chem 1996; 271 : 17114–8. [Google Scholar]
  32. Flamand N, Surette ME, Picard S, et al. Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils. Mol Pharmacol 2002; 62 : 250–6. [Google Scholar]
  33. Thibault N, Burelout C, Harbour D, et al. Occupancy of adenosine A2a receptors promotes fMLP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes. J Leukoc Biol 2002; 71 : 367–77. [Google Scholar]
  34. Lukashev D, Ohta A, Apasov S, et al. Cutting edge: physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo. J Immunol 2004; 173 : 21–4. [Google Scholar]
  35. Schulte G, Fredholm BB. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 2003; 15 : 813–27. [Google Scholar]
  36. Pouliot M, Gilbert C, Borgeat P, et al. Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. Faseb J 1998; 12 : 1109–23. [Google Scholar]
  37. Pierce A, Legrand D, Mazurier J. La lactoferrine : une protéine multifonctionnelle. Med Sci (Paris) 2009; 25 : 361–9. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.